InvestorsHub Logo
Followers 2
Posts 307
Boards Moderated 0
Alias Born 09/22/2006

Re: None

Monday, 03/18/2019 3:29:17 PM

Monday, March 18, 2019 3:29:17 PM

Post# of 34625
Inside the merger of TPIV with Marker technology forming MRKR... I'm curious.
To know.. looking at the Talpimune c/ trials, which in the lab and c/trials in the 1990's.. costing millions and reverse splits ( I've been through 2),at this point how many are " dry holes " how many show promise. Is the company giving up on vaccine therapy or not? Who can shed real light on this?
Regards the MRKR side,are their c/trials really promising as per the video?
Lastly, if there was not the merger, would the retail investor and the few funds have " pulled the plug?"

Fair questions I think even if a few get queasy. Thoughts and facts, please?
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent MRKR News